The French cosmetics giant continues to bet on data, algorithms and artificial intelligence through a partnership with Verily, the health division of Alphabet, Google’s parent company.
Exposome, aging, and deep biology of the skin
The partnership is expected to entail two programs aimed to better understand and characterize skin and hair aging mechanisms and to inform L’Oréal’s precision beauty tech strategy and product development.
The first is a strategic research collaboration to establish a longitudinal biological, clinical, environmental view of skin health. It combines L’Oréal’s scientific knowledge of skin and Verily’s comprehensive clinical science capabilities, to decode and discover the links between exposome, skin aging, and deep biology of the skin.
The second is a partnership with Verily’s R&D Team and L’Oréal’s Active Cosmetics Division, to explore the development of new technologies and tele-diagnosis solutions such as sensors, and AI algorithms for dermatology and skincare, that can form the basis for new services.
New era of skin health
“Thanks to this partnership, we want to lead a new era of skin health, through tech and science, to enable every person around the world the most inclusive, personalized, powerful and precise programs for their skin at each stage of their lives,” says Nicolas Hieronimus, Chief Executive Officer, L’Oréal Group.
